BB BIOTECH AG - 31 Dec 2024 SCHEDULE 13G/A Report for Agios Pharmaceuticals, Inc. Common Stock (AGIO)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Agios Pharmaceuticals, Inc. Common Stock
Symbol: AGIO
Shares outstanding: 56,695,968 shares
Disclosed Ownership: 3,515,150 shares
Ownership: 6.2%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 14:35:11 UTC
Date of event: 31 Dec 2024
Next filing: 13 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	6.2%	3,515,150	0	3,515,150	/s/ Martin Gubler	Martin Gubler/Signatory Authority
Biotech Target N.V.	6.2%	3,515,150	0	3,515,150	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority